Onderneming ICON PLC Irish S.E.
Aandelen
ICLR
IE0005711209
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Outsourced Development Services
100,0
%
| 7 741 | 100,0 % | 8 120 | 100,0 % | +4,89% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
40,4
%
| 3 575 | 46,2 % | 3 284 | 40,4 % | -8,14% |
Ireland
29,3
%
| 1 985 | 25,6 % | 2 377 | 29,3 % | +19,78% |
Rest of Europe
19,4
%
| 1 618 | 20,9 % | 1 575 | 19,4 % | -2,69% |
Other
10,9
%
| 564 | 7,3 % | 884 | 10,9 % | +56,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Brendan Brennan
DFI | Director of Finance/CFO | 45 | 01-01-06 |
Ciaran Murray
CHM | Chairman | 61 | 03-10-05 |
Tom O'Leary
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-01 |
Chief Administrative Officer | 49 | 01-11-09 | |
Gregory Licholai
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-11-21 |
Simon Holmes
CIO | Chief Investment Officer | - | 01-07-05 |
Joe Cronin
HRO | Human Resources Officer | - | 01-01-14 |
Paul McCracken
PRN | Corporate Officer/Principal | - | 14-10-16 |
Andrew Garrett
PRN | Corporate Officer/Principal | - | 14-10-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Climax
FOU | Founder | 71 | 01-06-90 |
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Linda Grais
BRD | Director/Board Member | 68 | 01-07-21 |
Ciaran Murray
CHM | Chairman | 61 | 03-10-05 |
Eugene McCague
BRD | Director/Board Member | 65 | 04-10-17 |
Joan Garahy
BRD | Director/Board Member | 61 | 20-11-17 |
Julie O'Neill
BRD | Director/Board Member | 58 | 23-07-19 |
Rónán Murphy
BRD | Director/Board Member | 66 | 18-10-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 82 683 805 | 82 142 753 ( 99,35 %) | 0 | 99,35 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
ICON Clinical Research India Pvt Ltd.
ICON Clinical Research India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, ICON Clinical Research India Pvt Ltd. is an Indian company that provides clinical research and development services. The company is based in Chennai, India. |
Miscellaneous Commercial Services
|
DOCS Resourcing Ltd.
DOCS Resourcing Ltd. Medical/Nursing ServicesHealth Services DOCS Resourcing Ltd., a subsidiary of ICON plc, is an Irish company that provides human health services. |
Medical/Nursing Services
|
ICON Global Treasury Unlimited Co.
ICON Global Treasury Unlimited Co. Financial ConglomeratesFinance Part of ICON plc, ICON Global Treasury Unlimited Co. is a company headquartered in Ireland that provides financial services. |
Financial Conglomerates
|
ICON Clinical Research Ltd.
ICON Clinical Research Ltd. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research Ltd., a subsidiary of ICON plc, is an Irish company located in Dublin. The firm provides consulting, outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government and public health organisations. |
Miscellaneous Commercial Services
|
Icon Investments (UK) Ltd.
| |
Icon Luxembourg SARL
Icon Luxembourg SARL Finance/Rental/LeasingFinance Part of ICON plc, Icon Luxembourg SARL is a financial institution. The company is based in Luxembourg, Luxembourg. Founded in 1998. |
Finance/Rental/Leasing
|
Icon Investments Five Unlimited Co.
Icon Investments Five Unlimited Co. MiscellaneousMiscellaneous Part of ICON plc, ICON Investments Five Unlimited Co. is an investment holding Irish company. The company is based in Dublin, Ireland. |
Miscellaneous
|
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. | |
-8,12% | 11,19 mld. |